Julie H Levison

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. pmc Shifting the HIV Training and Research Paradigm to Address Disparities in HIV Outcomes
    Julie H Levison
    Division of General Internal Medicine, Department of Medicine, Massachusetts General Hospital, 50 Staniford St, 9th Floor, Boston, MA, 02114, USA
    AIDS Behav 20:265-72. 2016
  2. pmc The clinical and economic impact of genotype testing at first-line antiretroviral therapy failure for HIV-infected patients in South Africa
    Julie H Levison
    Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA 02114, USA
    Clin Infect Dis 56:587-97. 2013
  3. pmc Virologic failure of protease inhibitor-based second-line antiretroviral therapy without resistance in a large HIV treatment program in South Africa
    Julie H Levison
    Division of General Medicine Massachusetts General Hospital, Boston, Massachusetts, United States of America
    PLoS ONE 7:e32144. 2012
  4. pmc Early outcomes and the virological effect of delayed treatment switching to second-line therapy in an antiretroviral roll-out programme in South Africa
    Julie H Levison
    Division of General Medicine, Massachusetts General Hospital, Boston, MA, USA
    Antivir Ther 16:853-61. 2011
  5. pmc Genotype assays and third-line ART in resource-limited settings: a simulation and cost-effectiveness analysis of a planned clinical trial
    Sarah B Lorenzana
    Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, and Harvard Medical School, Boston, MA 02114, USA
    AIDS 26:1083-93. 2012
  6. pmc Foreign-born status as a predictor of engagement in HIV care in a large US metropolitan health system
    Julie H Levison
    a Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA
    AIDS Care 29:244-251. 2017

Collaborators

Detail Information

Publications6

  1. pmc Shifting the HIV Training and Research Paradigm to Address Disparities in HIV Outcomes
    Julie H Levison
    Division of General Internal Medicine, Department of Medicine, Massachusetts General Hospital, 50 Staniford St, 9th Floor, Boston, MA, 02114, USA
    AIDS Behav 20:265-72. 2016
    ..Shifts in the research paradigm to include, retain, and promote Latino HIV/AIDS researchers will benefit the scientific process and the patients and communities who await the promise of HIV/AIDS research. ..
  2. pmc The clinical and economic impact of genotype testing at first-line antiretroviral therapy failure for HIV-infected patients in South Africa
    Julie H Levison
    Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA 02114, USA
    Clin Infect Dis 56:587-97. 2013
    ..After adherence counseling, these patients may safely and effectively continue first-line ART, thereby delaying more expensive second-line ART...
  3. pmc Virologic failure of protease inhibitor-based second-line antiretroviral therapy without resistance in a large HIV treatment program in South Africa
    Julie H Levison
    Division of General Medicine Massachusetts General Hospital, Boston, Massachusetts, United States of America
    PLoS ONE 7:e32144. 2012
    ..We investigated the prevalence of wild-type virus (no major drug resistance) and drug resistance mutations at second-line antiretroviral treatment (ART) failure in a large HIV treatment program in South Africa...
  4. pmc Early outcomes and the virological effect of delayed treatment switching to second-line therapy in an antiretroviral roll-out programme in South Africa
    Julie H Levison
    Division of General Medicine, Massachusetts General Hospital, Boston, MA, USA
    Antivir Ther 16:853-61. 2011
    ..We aimed to describe predictors of lack of virological suppression in HIV-infected patients on second-line ART in a roll-out programme in South Africa...
  5. pmc Genotype assays and third-line ART in resource-limited settings: a simulation and cost-effectiveness analysis of a planned clinical trial
    Sarah B Lorenzana
    Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, and Harvard Medical School, Boston, MA 02114, USA
    AIDS 26:1083-93. 2012
    ..To project the clinical and economic outcomes of a genotype assay for selection of third-line antiretroviral therapy (ART) in resource-limited settings, as per the planned international A5288 trial (MULTI-OCTAVE)...
  6. pmc Foreign-born status as a predictor of engagement in HIV care in a large US metropolitan health system
    Julie H Levison
    a Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA
    AIDS Care 29:244-251. 2017
    ..Interventions that promote HIV screening in foreign-born persons are a promising way to improve outcomes in these populations...